Print

Health Ministry proposes medical device rule changes to ease compliance, speed up market access

The Union Ministry of Health and Family Welfare (MoHFW) has proposed amendments to the Medical Devices Rules, 2017, aimed at simplifying regulatory requirements, improving transparency and facilitating faster market access for eligible medical devices.

The proposed reforms cover three key areas – outsourced sterilisation of medical devices, standardisation of testing fees and recognition of the European Union as a stringent regulatory jurisdiction for waiving clinical investigation requirements.

Under the amended provisions of Rule 44, manufacturers using outsourced sterilisation facilities will no longer need to obtain a separate loan licence under Rule 25, provided the sterilisation facility has a valid licence under the Medical Devices Rules, 2017.

Earlier, manufacturers without in-house sterilisation facilities were required to obtain a separate loan licence for sterilisation activities. The change is expected to reduce compliance requirements, documentation, approval timelines and associated costs, while making it easier for manufacturers to use specialised sterilisation facilities.

The amendments also introduce a Ninth Schedule prescribing uniform testing fees for medical devices tested by Medical Device Testing Laboratories. The standardised fee structure is intended to bring greater transparency and consistency to testing charges across laboratories.

According to the ministry, the move will provide manufacturers and importers with greater predictability, reduce ambiguity and disputes over testing charges, and promote equitable treatment of stakeholders.

In another major change, Rule 63 of the Medical Devices Rules, 2017 has been amended to include the European Union among the recognised stringent regulatory jurisdictions for waiving clinical investigation requirements for certain medical devices without predicate devices.

The provision currently recognises the United States, United Kingdom, Australia, Canada and Japan. With the inclusion of the EU, eligible medical devices that have already received approval in the European Union could gain faster access to the Indian market, while reducing regulatory burdens and timelines for manufacturers and importers.

The Ministry said the reforms are expected to lower compliance costs, simplify regulatory processes and improve transparency and predictability in the medical device sector.

The measures are also aimed at promoting greater international regulatory convergence while maintaining high standards of quality, safety and performance of medical devices, the ministry said.

The reforms form part of the government’s broader efforts to promote Ease of Doing Business in the medical device sector and facilitate timely availability of advanced and innovative medical technologies in India.

RELATED ARTICLES

48 mins ago | ind vs nz

NZ skipper Latham highlights Bumrah challenge; hails Kiwis pace “leader” Matt Henry ahead of 1st Test against India

New Zealand skipper Tom Latham spoke on Kiwis facing Indian pace superstar Jasprit Bumrah, saying that his unique action is going to make facing him a huge challenge. Following India's series wins in the T20I and ODI legs of the series, the inaugu...

49 mins ago | Finance and Contract Committee

Municipal Corporation of Gurugram approves development projects worth Rs 61 crore

The Municipal Corporation of Gurugram (MCG) has approved development projects and civic amenities worth over Rs 61.10 crore at the 11th meeting of its Finance and Contract Committee (F&CC), an official said. The meeting was held on Tuesday under...

54 mins ago | US and Iran

US, Iran exchange fire despite talks with mediators

The US and Iran exchanged fire on Tuesday, with the US striking an Iranian missile launch site after Iran said it targeted a US military radar system in Bahrain, despite talks between Iran and mediators Oman and Qatar. The latest back-and-forth betw...